靶向CD44变异体5的抗体-药物偶联物作为肝内胆管癌新型治疗方案
Targeting CD44 Variant 5 by an Antibody‒Drug Conjugate as a Novel Therapeutic Regimen for Intrahepatic Cholangiocarcinoma
Bei Yuncheng, He Jian, Dong Xuhui, Wang Yuxin, Guo Wan, Cai Chengjie, Xu Zhiye, Wei Jia, Liu Baorui, Shen Pingping
Journal：Cell Reports Medicine
IF：16.99
DOI：10.2139/ssrn.4290063
PMID：
Published：2022-12-07
research field：肿瘤学分子生物学药理学
Abstract
本文使用的Yeasen产品
相关产品
产品应用
